封面
市场调查报告书
商品编码
1566930

预立指示市场:按组成部分、人口统计和最终用户:2024-2033 年全球机会分析和产业预测

Advance Directives Market By Component , By Demographics (Elderly Population , Middle Aged , Young Adults ) By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日期: | 出版商: Allied Market Research | 英文 231 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,预立医疗指示市场价值为 1,217 亿美元,预估 2024 年至 2033 年复合年增长率为 15.4%,至 2033 年达到 5,102 亿美元。

预立医疗指示是一份法律文件,允许个人在因严重或受伤而无法沟通或做出决定的情况下概述他们对医疗照护的愿望。这些文件是规划未来医疗保健需求并确保个人意愿得到尊重和遵守的重要工具,即使在个人无法表达其意愿的情况下也是如此。作为表达医疗偏好的一种明确且具有法律约束力的方式,它为医疗保健专业人员提供瞭如何进行医疗干预措施并使其与患者的价值观和偏好保持一致的适当指南。

人们越来越意识到规划临终关怀和医疗决策的必要性是全球预立医疗指示市场的关键驱动力。许多国家的政府已采取倡议,提高人们对预立医疗指示重要性的认识,并鼓励个人记录其医疗照护偏好。例如,美国政府的国家医疗决策日定于每年的4月16日。该计划的重点是教育医疗保健提供者和消费者有关预先护理计划的知识,并在危机发生之前就护理和服务做出明智的决定。然而,缺乏对预立医疗指示的认识是全球市场的一个主要阻碍因素。美国国家生物技术资讯中心(全球最大的可免费取得的生物医学和基因组资讯资料库)发表的一项研究发现,拥有预先医疗指示的人更有可能出现潜在增加,但仅增加 5% 至 25%。相反,老年人口的增加预计将为市场成长提供有利的机会。随着人口老化,人们越来越意识到规划临终关怀和医疗决策的必要性。科技的进步还可以使预立医疗指示的创建过程变得更加容易和方便,例如开发用户友好的数位平台和行动应用程式来创建和储存预先医疗指示。

预立指示市场分为组成部分、人口统计、最终使用者和地区。按组件划分,市场分为软体和服务。依人口结构,人口分为老年人(65岁以上)、中老年人(40至60岁)、青年(18至39岁)。按最终用户,可分为付款人、提供者和其他。从区域来看,分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从组成部分来看,服务业将在 2023 年获得较大的市场占有率。

按人口统计,老年人群体在 2023 年引领预立医疗指示市场。

按最终用户划分,医疗保健提供者细分市场将在 2023 年占据显着地位。

按地区划分,预计北美将在 2033 年占据市场主导地位。

可以自订此报告(需要额外的费用和时间表)

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料(Excel格式,包括位置、联络资讯、供应商/供应商网路等)

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章 预设医疗指示市场:依组成部分

  • 市场概况
  • 软体
  • 服务

第五章先进医疗市场:依人口统计

  • 市场概况
  • 老年人口(65岁以上)
  • 中年(40-60岁)
  • 青少年(18-39岁)

第六章 预设医疗指示市场:依最终使用者分类

  • 市场概况
  • 付款人
  • 提供者
  • 其他的

第七章 预设医疗指示市场:依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国预立医疗指示市场
    • 加拿大预立医疗指示市场
    • 墨西哥预立医疗指示市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国的预先医疗指示市场
    • 法国预立医疗指示市场
    • 英国预立医疗指示市场
    • 义大利预立指示市场
    • 西班牙的预立医疗指示市场
    • 其他欧洲国家预立指示市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本的预立医疗指示市场
    • 中国的预设医疗指示市场
    • 印度预立医疗指示市场
    • 澳洲预立医疗指示市场
    • 韩国预立指示市场
    • 其他亚太地区预立医疗指示市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西预立医疗指示市场
    • 沙乌地阿拉伯预立医疗指示市场
    • 南非预立医疗指示市场
    • 其他拉丁美洲/中东/非洲预立指示市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位(2023年)

第九章 公司简介

  • West Health
  • MyDirectives, Inc.
  • Aledade
  • VyncaCare
  • WiserCare
  • Sharp HealthCare
  • Vital Decisions LLC
  • Affirm Health
  • Thanacare
  • Honor My Decisions LLC
简介目录
Product Code: A323962

The advance directives market was valued at $121.7 billion in 2023, and is projected to reach $510.2 billion by 2033, growing at a CAGR of 15.4% from 2024 to 2033.

Advance directives are legal documents that allow individuals to outline their preferences for medical care in the event that they become unable to communicate or make decisions for themselves due to a serious illness or injury. These documents are vital tools for planning future healthcare needs, ensuring that a person's wishes are respected and adhered to during times when they may be unable to voice their decision. They provide a clear and legally binding way for individuals to express their medical care preferences, thus assisting healthcare professionals with appropriate guidance on how to proceed with treatment and aligning medical interventions with the patient's values and desires.

Rise in awareness of the need for planning end-of-life care and medical decision-making acts as the key driving force of the global advance directives market. Governments of many countries have taken initiatives to raise awareness about the importance of advance directives and encourage individuals to document their medical care preferences. For instance, National Healthcare Decision Day initiated by the U.S. Government is held on April 16 each year. This initiative emphasizes on educating healthcare providers and consumers about advance care planning and make informed decisions about care and services before a crisis. However, lack of awareness regarding advance directives acts as a key deterrent factor of the global market. According to a study published by the National Center for Biotechnology Information-the world's largest database of freely accessible biomedical and genomic information-merely 5% to 25% individuals hold advance directives, although this might increase with age and hospitalization. On the contrary, increase in geriatric population is expected to offer remunerative opportunities for the growth of the market. As the population ages, there is an increased awareness of the need for planning end-of-life care and medical decision-making. In addition, advancements in technology such as developing user-friendly digital platforms and mobile apps for creating and storing advance directives can make the process more accessible and convenient.

The advance directives market is segmented into component, demographic, end user, and region. On the basis of component, the market is bifurcated into software and services. By demographic, it is divided into elderly population (65 years & above), middle aged (40-60 years), and young adults (18-39 years) . Depending on end user, it is classified into payers, providers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By component, the services segment acquired significant market share in 2023.

On the basis of demographic, the elderly population segment led the advance directives market in 2023.

Depending on end user, the healthcare providers segment held a prominent position in market in 2023.

Region wise, North America is poised to dominate the market 2033.

Competition Analysis

Competitive analysis and profiles of the major players in the global advance directives market include West Health , MyDirectives, Inc., Aledade, VyncaCare, WiserCare, Sharp HealthCare, Vital Decisions LLC, Affirm Health, thanacare, and Honor My Decisions LLC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Component

  • Software
  • Services

By Demographics

  • Elderly Population (65 yrs above)
  • Middle Aged (40-60 yrs)
  • Young Adults (18-39 yrs)

By End User

  • Payers
  • Providers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • West Health
    • MyDirectives, Inc.
    • Aledade
    • VyncaCare
    • WiserCare
    • Sharp HealthCare
    • Vital Decisions LLC
    • Affirm Health
    • thanacare
    • Honor My Decisions LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ADVANCE DIRECTIVES MARKET, BY COMPONENT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Component
  • 4.2. Software
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Services
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Demographics
  • 5.2. Elderly Population (65 Yrs Above)
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Middle Aged (40-60 Yrs)
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Young Adults (18-39 Yrs)
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ADVANCE DIRECTIVES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Payers
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Providers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ADVANCE DIRECTIVES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Component
    • 7.2.3. Market Size and Forecast, By Demographics
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Advance Directives Market
      • 7.2.6.1. Market Size and Forecast, By Component
      • 7.2.6.2. Market Size and Forecast, By Demographics
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Advance Directives Market
      • 7.2.7.1. Market Size and Forecast, By Component
      • 7.2.7.2. Market Size and Forecast, By Demographics
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Advance Directives Market
      • 7.2.8.1. Market Size and Forecast, By Component
      • 7.2.8.2. Market Size and Forecast, By Demographics
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Component
    • 7.3.3. Market Size and Forecast, By Demographics
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Advance Directives Market
      • 7.3.6.1. Market Size and Forecast, By Component
      • 7.3.6.2. Market Size and Forecast, By Demographics
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Advance Directives Market
      • 7.3.7.1. Market Size and Forecast, By Component
      • 7.3.7.2. Market Size and Forecast, By Demographics
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Advance Directives Market
      • 7.3.8.1. Market Size and Forecast, By Component
      • 7.3.8.2. Market Size and Forecast, By Demographics
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Advance Directives Market
      • 7.3.9.1. Market Size and Forecast, By Component
      • 7.3.9.2. Market Size and Forecast, By Demographics
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Advance Directives Market
      • 7.3.10.1. Market Size and Forecast, By Component
      • 7.3.10.2. Market Size and Forecast, By Demographics
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Advance Directives Market
      • 7.3.11.1. Market Size and Forecast, By Component
      • 7.3.11.2. Market Size and Forecast, By Demographics
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Component
    • 7.4.3. Market Size and Forecast, By Demographics
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Advance Directives Market
      • 7.4.6.1. Market Size and Forecast, By Component
      • 7.4.6.2. Market Size and Forecast, By Demographics
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Advance Directives Market
      • 7.4.7.1. Market Size and Forecast, By Component
      • 7.4.7.2. Market Size and Forecast, By Demographics
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Advance Directives Market
      • 7.4.8.1. Market Size and Forecast, By Component
      • 7.4.8.2. Market Size and Forecast, By Demographics
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Advance Directives Market
      • 7.4.9.1. Market Size and Forecast, By Component
      • 7.4.9.2. Market Size and Forecast, By Demographics
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Advance Directives Market
      • 7.4.10.1. Market Size and Forecast, By Component
      • 7.4.10.2. Market Size and Forecast, By Demographics
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Advance Directives Market
      • 7.4.11.1. Market Size and Forecast, By Component
      • 7.4.11.2. Market Size and Forecast, By Demographics
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Component
    • 7.5.3. Market Size and Forecast, By Demographics
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Advance Directives Market
      • 7.5.6.1. Market Size and Forecast, By Component
      • 7.5.6.2. Market Size and Forecast, By Demographics
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Advance Directives Market
      • 7.5.7.1. Market Size and Forecast, By Component
      • 7.5.7.2. Market Size and Forecast, By Demographics
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Advance Directives Market
      • 7.5.8.1. Market Size and Forecast, By Component
      • 7.5.8.2. Market Size and Forecast, By Demographics
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Advance Directives Market
      • 7.5.9.1. Market Size and Forecast, By Component
      • 7.5.9.2. Market Size and Forecast, By Demographics
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. West Health
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. MyDirectives, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Aledade
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. VyncaCare
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. WiserCare
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Sharp HealthCare
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Vital Decisions LLC
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Affirm Health
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Thanacare
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Honor My Decisions LLC
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments